ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft

ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft

10.1016/j.jhep.2008.08.010

Saved in:
Bibliographic Details
Main Authors: Jasinghe, V.J., Xie, Z., Zhou, J., Khng, J., Poon, L.-F., Senthilnathan, P., Chen, C.-S., Albert, D.H., Davidsen, S.K.
Other Authors: MEDICINE
Format: Article
Published: 2011
Subjects:
ABT-869
Angiogenesis
Hepatocellular carcinoma
mTOR pathway
Rapamycin
Tyrosine kinase inhibitor
Online Access:http://scholarbank.nus.edu.sg/handle/10635/26815
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Similar Items

Similar Items